Pellepharm

Biotechnology company pioneering precision medicine for rare dermatological conditions

placeMenlo Park, California, United States calendar_todayFounded 2012 groups8 employees language pellepharm.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 1,689 times.

YearFilings
20161
20172
20181
20191
20201
20211
20221
20231
20251

Investor mix

3 investors on record; lead investors include BridgeBio; 1 has since exited.

Investor typeCountShare
Private equity133%
Other / undisclosed267%
Coming soon